Caladrius Biosciences Inc CLBS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:43 AM EDT
1.67quote price arrow up+0.05 (+3.09%)
Volume
379,343
52 week range
1.25 - 4.89

...

Loading . . .
  • Open1.64
  • Day High1.68
  • Day Low1.62
  • Prev Close1.62
  • 52 Week High4.89
  • 52 Week High Date01/20/21
  • 52 Week Low1.25
  • 52 Week Low Date12/14/20

Key Stats

  • Market Cap99.37M
  • Shares Out59.50M
  • 10 Day Average Volume0.62M
  • Dividend-
  • Dividend Yield-
  • Beta1.06
  • YTD % Change16.78

KEY STATS

  • Open1.64
  • Day High1.68
  • Day Low1.62
  • Prev Close1.62
  • 52 Week High4.89
  • 52 Week High Date01/20/21
  • 52 Week Low1.25
  • 52 Week Low Date12/14/20
  • Market Cap99.37M
  • Shares Out59.50M
  • 10 Day Average Volume0.62M
  • Dividend-
  • Dividend Yield-
  • Beta1.06
  • YTD % Change16.78

RATIOS/PROFITABILITY

  • EPS (TTM)-0.25
  • P/E (TTM)-6.56
  • Fwd P/E (NTM)-5.06
  • EBITDA (MRQ)-23.11M
  • ROE (MRQ)-19.17%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)9.15%
  • Net Margin (MRQ)-179.78%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/11/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Caladrius Biosciences Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Caladrius Biosciences, Inc. is a late-stage therapeutics development biopharmaceutical company that provides cell therapies for cardiovascular and autoimmune diseases. The Company’s product candidates include three developmental treatments for cardiovascular diseases based on its classification determinant34+ (CD34+) cell therapy platform. Its CLBS12 product candidate is a recipient of a SAKIGAKE designation in Japan and advanced therapy medicinal product classification...
Gregory Brown M.D.
Chairman
David Mazzo Ph.D.
President
Address
110 Allen Rd
Basking Ridge, NJ
07920-4500
United States

Top Peers

SYMBOLLASTCHG%CHG
LUMO
Lumos Pharma Inc
11.66+0.17+1.48%
NDRA
ENDRA Life Sciences Inc
2.29-0.08-3.59%
ETTX
Entasis Therapeutics Holdings Inc
2.86+0.18+6.53%
OGEN
Oragenics Inc
0.7725-0.0272-3.4013%
TCON
TRACON Pharmaceuticals Inc
6.46-0.06-0.92%